Halo Pharmaceutical Names New CEO and CFO

From DCAT Value Chain Insights (VCI)

By People On The Move posted 08-28-2015 17:34


Halo Pharmaceutical, a contract development and manufacturing organization has appointed Lee Karras as its chief executive officer and Barry Lederman as its chief financial officer (CFO).

Mr. Karrashas more than 25 years of healthcare industry related experience. Prior to joining Halo, he was president of IBA Molecular North America, a manufacturer and distributor of radiopharmaceuticals. Prior to joining Halo, Mr. Lederman served as the vice rresident and CFO for Eisai Inc. with operations in the Americas region, the CFO at Wedgewood Pharmacy, Nycomed US Inc., and Qualitrol Company LLC (a subsidiary of Danaher Corporation). He also spent 10 years with Roche in positions of increasing responsibility within finance, culminating in his appointment as senior vice president, head of business analysis and controlling at Roche Centralized Diagnostics, headquartered in Mannheim, Germany.

Halo has facilities in Whippany and East Hanover, New Jersey and Montreal, Quebec Canada. It has capabilities in a variety of dosage forms, including tablets, capsules, powders, liquids, creams, sterile and non-sterile ointments and suppositories.

Source: Halo Pharmaceutical


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription